(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors

NCT02508532 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Stromal Tumors (GIST)
Other Relapsed or Refractory Solid Tumors

Interventions

DRUG: Avapritinib

Sponsor

Blueprint Medicines Corporation